Review




Structured Review

Procell Inc rat bone marrow mesenchymal stem cells bmscs
Evaluation of biocompatibility, adhesion and migration ability of both <t>BMSCs</t> and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Rat Bone Marrow Mesenchymal Stem Cells Bmscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12686661-77-0-23?v=Procell+Inc
Average 86 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells bmscs - by Bioz Stars, 2026-08
86/100 stars

Images

1) Product Images from "Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications"

Article Title: Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications

Journal: Bioactive Materials

doi: 10.1016/j.bioactmat.2025.11.012

Evaluation of biocompatibility, adhesion and migration ability of both BMSCs and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Figure Legend Snippet: Evaluation of biocompatibility, adhesion and migration ability of both BMSCs and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Techniques Used: Migration, CCK-8 Assay, Staining, Cell Culture, Transwell Assay

Evaluation of angiogenic, and osteogenic abilities in vitro . (A) Immunofluorescence staining of HUVECs for VEGF. (B) Fluorescence intensity quantification of VEGF. (C and D) The expression levels of angiogenesis-related genes VEGF and HIF-1α in HUVECs. (E) ELISA analysis of VEGF secretion by HUVECs. (F) Western blot analysis of angiogenesis-related proteins in HUVECs. (G and H) Quantitative analysis of Western blot in HUVECs normalized to β-actin. (I) Images of ALP staining on day 7 and 14. (J) Images of ARS staining on day 21 and 28. (K) Quantitative analysis of ALP detected by the ALP assay. (L) Quantitative analysis of calcium nodule elution. (M) Immunofluorescence staining of BMSCs for OPN. (N) Fluorescence intensity quantification of OPN. (O–Q) The expression levels of osteogenic-related genes OPN, COL-I and ALP in BMSCs. (R) Western blot analysis of osteogenesis-related proteins in BMSCs. (S–U) Quantitative analysis of Western blot in BMSCs normalized to β-actin. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Figure Legend Snippet: Evaluation of angiogenic, and osteogenic abilities in vitro . (A) Immunofluorescence staining of HUVECs for VEGF. (B) Fluorescence intensity quantification of VEGF. (C and D) The expression levels of angiogenesis-related genes VEGF and HIF-1α in HUVECs. (E) ELISA analysis of VEGF secretion by HUVECs. (F) Western blot analysis of angiogenesis-related proteins in HUVECs. (G and H) Quantitative analysis of Western blot in HUVECs normalized to β-actin. (I) Images of ALP staining on day 7 and 14. (J) Images of ARS staining on day 21 and 28. (K) Quantitative analysis of ALP detected by the ALP assay. (L) Quantitative analysis of calcium nodule elution. (M) Immunofluorescence staining of BMSCs for OPN. (N) Fluorescence intensity quantification of OPN. (O–Q) The expression levels of osteogenic-related genes OPN, COL-I and ALP in BMSCs. (R) Western blot analysis of osteogenesis-related proteins in BMSCs. (S–U) Quantitative analysis of Western blot in BMSCs normalized to β-actin. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Techniques Used: In Vitro, Immunofluorescence, Staining, Fluorescence, Expressing, Enzyme-linked Immunosorbent Assay, Western Blot, ALP Assay



Similar Products

86
Procell Inc rat bone marrow mesenchymal stem cells bmscs
Evaluation of biocompatibility, adhesion and migration ability of both <t>BMSCs</t> and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Rat Bone Marrow Mesenchymal Stem Cells Bmscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12686661-77-0-23?v=Procell+Inc
Average 86 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells bmscs - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Servicebio Inc rat bone marrow derived mesenchymal stem cells bmscs
PTP promotes the transformation of hematopoiesis to a youthful state by improving the hematopoietic microenvironment in the bone marrow. (A) Representative SA‐β‐gal staining of rat bone marrow (scale bars, 200 μm) (B) Quantification of SA‐β‐gal + cells per area, n = 3/group. (C) TGF‐β1 (pg/mL) and TPO (pg/mL) in rat bone marrow, n = 3/group. (D–N) The proportion of lin − cell subsets (HSC, LT‐HSC, ST‐HSC, MPP1, MPP5, MPP2, MPP3, CMP, MPP4, CLP, Pre GM, GMP, Pre MegE, MEP, MKP) in mice bone marrow cells, n = 3–4/group. Statistical analysis: One‐way ANOVA and Bonferroni post‐test. (O) Multiple cytokine profiling quantification of SASP proteins in mice bone marrow, log2‐transformed fold change in mean fluorescence intensity (MFI) compared to the average of D‐gal group, n = 6/group. (P) Representative examples and (Q) quantification of SEC (CD31 low Sca‐1 low ) and AEC (CD31 hi Sca‐1 hi ) in ECs from rat bone marrow and endosteum was detected by flow cytometry, n = 3/group. (R) The third generation of rat <t>bone</t> <t>marrow‐derived</t> <t>BMSCs</t> were cultured for 8 days. Cell viability was measured by MTT assay, n = 5/group. (S–T) Western blot of P16, P21, P27, and P63 expression in rat bone marrow‐derived BMSCs, n = 4/group. (U) Cell cycle analysis of rat bone marrow‐derived BMSCs by flow cytometry, n = 3/group. (V) Quantification of cell cycle phase distribution, n = 3/group. (W) Apoptosis of the third generation of rat bone marrow‐derived BMSCs using Annexin V‐FITC/PI KIT combined with flow cytometry, n = 3/group. Statistical analysis: One‐way ANOVA, Bonferroni post‐test for (D–N) and Tukey post‐test for the others, Data are mean ± SD; error bars denote 95% CI; * p < 0.05, ** p < 0.01, *** p < 0.001.
Rat Bone Marrow Derived Mesenchymal Stem Cells Bmscs, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12862434-361-0-17?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
rat bone marrow derived mesenchymal stem cells bmscs - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Dawley Inc rat bone marrow mesenchymal stem cells bmscs
Evaluation of the cytocompatibility of PRP-CMCS-TA hydrogel. (A,B) CCK-8 assay for cytotoxicity on day 1 and day 2. Data are presented as mean ± SD (n = 6 independent replicates). (C) Live cell staining of <t>BMSCs</t> in three groups. (D) Images of Transwell assays for BMSCs in three groups. Statistical significance was determined by one-way ANOVA. *p < 0.05, ** p < 0.01,”ns” represents no significant difference.
Rat Bone Marrow Mesenchymal Stem Cells Bmscs, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12611839-67-0-17?v=Dawley+Inc
Average 86 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells bmscs - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Servicebio Inc rat bone marrow mesenchymal stem cells bmscs
Evaluation of the cytocompatibility of PRP-CMCS-TA hydrogel. (A,B) CCK-8 assay for cytotoxicity on day 1 and day 2. Data are presented as mean ± SD (n = 6 independent replicates). (C) Live cell staining of <t>BMSCs</t> in three groups. (D) Images of Transwell assays for BMSCs in three groups. Statistical significance was determined by one-way ANOVA. *p < 0.05, ** p < 0.01,”ns” represents no significant difference.
Rat Bone Marrow Mesenchymal Stem Cells Bmscs, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/10__1016_slash_j__compstruct__2025__119551-78-0-10?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells bmscs - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
Cyagen Biosciences rat bone marrow mesenchymal stem cells (bmscs, rasmx-01001)
Evaluation of the cytocompatibility of PRP-CMCS-TA hydrogel. (A,B) CCK-8 assay for cytotoxicity on day 1 and day 2. Data are presented as mean ± SD (n = 6 independent replicates). (C) Live cell staining of <t>BMSCs</t> in three groups. (D) Images of Transwell assays for BMSCs in three groups. Statistical significance was determined by one-way ANOVA. *p < 0.05, ** p < 0.01,”ns” represents no significant difference.
Rat Bone Marrow Mesenchymal Stem Cells (Bmscs, Rasmx 01001), supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12059345-64-0-8?v=Cyagen+Biosciences
Average 90 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells (bmscs, rasmx-01001) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Dawley Inc rat bone marrow mesenchymal stem cells (bmscs)
LA@BC promoted <t>BMSCs</t> Osteogenic differentiation in vitro . (A) Live (green)/dead (red) staining of BMSCs after 24 h. (B) Cell proliferation of BMSCs cultured with BC, LA@BC for 24, 48 and 72 h (C) ALP staining of BMSCs after 7 days. (D) Alizarin Red S staining of BMSCs after 21 days. (E, F) Quantitative analysis of ALP staining, and Alizarin Red S staining. (G, H) Relative mRNA expression of Wnt, and β-catenin of BMSCs on day 7. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Rat Bone Marrow Mesenchymal Stem Cells (Bmscs), supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+bone+marrow+mesenchymal+stem+cells+bmscs/pmc12106357-67-1-18?v=Dawley+Inc
Average 90 stars, based on 1 article reviews
rat bone marrow mesenchymal stem cells (bmscs) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Evaluation of biocompatibility, adhesion and migration ability of both BMSCs and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Journal: Bioactive Materials

Article Title: Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications

doi: 10.1016/j.bioactmat.2025.11.012

Figure Lengend Snippet: Evaluation of biocompatibility, adhesion and migration ability of both BMSCs and HUVECs on CoCrMo-Mg scaffold. (A) Biocompatibility of BMSCs: (a) CCK-8 assay; (b) Live/dead staining of BMSCs at day 3; (c) Quantitative statistics of cell proliferation. (B) Biocompatibility of HUVECs: (a) CCK-8 assay; (b) Live/dead staining of HUVECs at day 3; (c) Quantitative statistics of cell proliferation. (C) Cell adhesion of BMSCs: (a) FE-SEM and EDS images of BMSCs co-cultured with CoCrMo and CoCrMo-Mg scaffolds for 48 h; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (D) Cell adhesion of HUVECs: (a) FE-SEM and EDS images of HUVECs; (b) Quantitative statistics of cell length; (c) Quantitative statistics of filopodia per cell. (E) The process of Transwell assay in BMSCs and HUVECs cultured with CoCrMo and CoCrMo-Mg scaffolds. (F) Crystalline violet staining of migrated cells. (G) Migration counts of BMSCs and HUVECs. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: Rat bone marrow mesenchymal stem cells (BMSCs), human umbilical vein endothelial cells (HUVECs), and RAW264.7 murine macrophage cell line (RAW264.7) were purchased from Procell Life Science & Technology Co., Ltd. (Wuhan, China).

Techniques: Migration, CCK-8 Assay, Staining, Cell Culture, Transwell Assay

Evaluation of angiogenic, and osteogenic abilities in vitro . (A) Immunofluorescence staining of HUVECs for VEGF. (B) Fluorescence intensity quantification of VEGF. (C and D) The expression levels of angiogenesis-related genes VEGF and HIF-1α in HUVECs. (E) ELISA analysis of VEGF secretion by HUVECs. (F) Western blot analysis of angiogenesis-related proteins in HUVECs. (G and H) Quantitative analysis of Western blot in HUVECs normalized to β-actin. (I) Images of ALP staining on day 7 and 14. (J) Images of ARS staining on day 21 and 28. (K) Quantitative analysis of ALP detected by the ALP assay. (L) Quantitative analysis of calcium nodule elution. (M) Immunofluorescence staining of BMSCs for OPN. (N) Fluorescence intensity quantification of OPN. (O–Q) The expression levels of osteogenic-related genes OPN, COL-I and ALP in BMSCs. (R) Western blot analysis of osteogenesis-related proteins in BMSCs. (S–U) Quantitative analysis of Western blot in BMSCs normalized to β-actin. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Journal: Bioactive Materials

Article Title: Magnesium ion implantation enhances the osseointegration and vascularization of 3D-Printed CoCrMo alloy scaffolds for load-bearing orthopedic applications

doi: 10.1016/j.bioactmat.2025.11.012

Figure Lengend Snippet: Evaluation of angiogenic, and osteogenic abilities in vitro . (A) Immunofluorescence staining of HUVECs for VEGF. (B) Fluorescence intensity quantification of VEGF. (C and D) The expression levels of angiogenesis-related genes VEGF and HIF-1α in HUVECs. (E) ELISA analysis of VEGF secretion by HUVECs. (F) Western blot analysis of angiogenesis-related proteins in HUVECs. (G and H) Quantitative analysis of Western blot in HUVECs normalized to β-actin. (I) Images of ALP staining on day 7 and 14. (J) Images of ARS staining on day 21 and 28. (K) Quantitative analysis of ALP detected by the ALP assay. (L) Quantitative analysis of calcium nodule elution. (M) Immunofluorescence staining of BMSCs for OPN. (N) Fluorescence intensity quantification of OPN. (O–Q) The expression levels of osteogenic-related genes OPN, COL-I and ALP in BMSCs. (R) Western blot analysis of osteogenesis-related proteins in BMSCs. (S–U) Quantitative analysis of Western blot in BMSCs normalized to β-actin. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: Rat bone marrow mesenchymal stem cells (BMSCs), human umbilical vein endothelial cells (HUVECs), and RAW264.7 murine macrophage cell line (RAW264.7) were purchased from Procell Life Science & Technology Co., Ltd. (Wuhan, China).

Techniques: In Vitro, Immunofluorescence, Staining, Fluorescence, Expressing, Enzyme-linked Immunosorbent Assay, Western Blot, ALP Assay

PTP promotes the transformation of hematopoiesis to a youthful state by improving the hematopoietic microenvironment in the bone marrow. (A) Representative SA‐β‐gal staining of rat bone marrow (scale bars, 200 μm) (B) Quantification of SA‐β‐gal + cells per area, n = 3/group. (C) TGF‐β1 (pg/mL) and TPO (pg/mL) in rat bone marrow, n = 3/group. (D–N) The proportion of lin − cell subsets (HSC, LT‐HSC, ST‐HSC, MPP1, MPP5, MPP2, MPP3, CMP, MPP4, CLP, Pre GM, GMP, Pre MegE, MEP, MKP) in mice bone marrow cells, n = 3–4/group. Statistical analysis: One‐way ANOVA and Bonferroni post‐test. (O) Multiple cytokine profiling quantification of SASP proteins in mice bone marrow, log2‐transformed fold change in mean fluorescence intensity (MFI) compared to the average of D‐gal group, n = 6/group. (P) Representative examples and (Q) quantification of SEC (CD31 low Sca‐1 low ) and AEC (CD31 hi Sca‐1 hi ) in ECs from rat bone marrow and endosteum was detected by flow cytometry, n = 3/group. (R) The third generation of rat bone marrow‐derived BMSCs were cultured for 8 days. Cell viability was measured by MTT assay, n = 5/group. (S–T) Western blot of P16, P21, P27, and P63 expression in rat bone marrow‐derived BMSCs, n = 4/group. (U) Cell cycle analysis of rat bone marrow‐derived BMSCs by flow cytometry, n = 3/group. (V) Quantification of cell cycle phase distribution, n = 3/group. (W) Apoptosis of the third generation of rat bone marrow‐derived BMSCs using Annexin V‐FITC/PI KIT combined with flow cytometry, n = 3/group. Statistical analysis: One‐way ANOVA, Bonferroni post‐test for (D–N) and Tukey post‐test for the others, Data are mean ± SD; error bars denote 95% CI; * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Aging Cell

Article Title: Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function

doi: 10.1111/acel.70400

Figure Lengend Snippet: PTP promotes the transformation of hematopoiesis to a youthful state by improving the hematopoietic microenvironment in the bone marrow. (A) Representative SA‐β‐gal staining of rat bone marrow (scale bars, 200 μm) (B) Quantification of SA‐β‐gal + cells per area, n = 3/group. (C) TGF‐β1 (pg/mL) and TPO (pg/mL) in rat bone marrow, n = 3/group. (D–N) The proportion of lin − cell subsets (HSC, LT‐HSC, ST‐HSC, MPP1, MPP5, MPP2, MPP3, CMP, MPP4, CLP, Pre GM, GMP, Pre MegE, MEP, MKP) in mice bone marrow cells, n = 3–4/group. Statistical analysis: One‐way ANOVA and Bonferroni post‐test. (O) Multiple cytokine profiling quantification of SASP proteins in mice bone marrow, log2‐transformed fold change in mean fluorescence intensity (MFI) compared to the average of D‐gal group, n = 6/group. (P) Representative examples and (Q) quantification of SEC (CD31 low Sca‐1 low ) and AEC (CD31 hi Sca‐1 hi ) in ECs from rat bone marrow and endosteum was detected by flow cytometry, n = 3/group. (R) The third generation of rat bone marrow‐derived BMSCs were cultured for 8 days. Cell viability was measured by MTT assay, n = 5/group. (S–T) Western blot of P16, P21, P27, and P63 expression in rat bone marrow‐derived BMSCs, n = 4/group. (U) Cell cycle analysis of rat bone marrow‐derived BMSCs by flow cytometry, n = 3/group. (V) Quantification of cell cycle phase distribution, n = 3/group. (W) Apoptosis of the third generation of rat bone marrow‐derived BMSCs using Annexin V‐FITC/PI KIT combined with flow cytometry, n = 3/group. Statistical analysis: One‐way ANOVA, Bonferroni post‐test for (D–N) and Tukey post‐test for the others, Data are mean ± SD; error bars denote 95% CI; * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Rat bone marrow‐derived mesenchymal stem cells (BMSCs) were isolated and cultured in Dulbecco's Modified Eagle's Medium (DMEM, Servicebio, G4510) supplemented with 1% fetal bovine serum (FBS, TIANHANG, 11011‐8611) at 37°C in a 5% CO 2 atmosphere.

Techniques: Transformation Assay, Staining, Fluorescence, Flow Cytometry, Derivative Assay, Cell Culture, MTT Assay, Western Blot, Expressing, Cell Cycle Assay

Evaluation of the cytocompatibility of PRP-CMCS-TA hydrogel. (A,B) CCK-8 assay for cytotoxicity on day 1 and day 2. Data are presented as mean ± SD (n = 6 independent replicates). (C) Live cell staining of BMSCs in three groups. (D) Images of Transwell assays for BMSCs in three groups. Statistical significance was determined by one-way ANOVA. *p < 0.05, ** p < 0.01,”ns” represents no significant difference.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: PRP-loaded hydrogel for rotator cuff repair by promoting osteogenic differentiation and tendon regeneration

doi: 10.3389/fbioe.2025.1655809

Figure Lengend Snippet: Evaluation of the cytocompatibility of PRP-CMCS-TA hydrogel. (A,B) CCK-8 assay for cytotoxicity on day 1 and day 2. Data are presented as mean ± SD (n = 6 independent replicates). (C) Live cell staining of BMSCs in three groups. (D) Images of Transwell assays for BMSCs in three groups. Statistical significance was determined by one-way ANOVA. *p < 0.05, ** p < 0.01,”ns” represents no significant difference.

Article Snippet: Rat bone marrow mesenchymal stem cells (BMSCs) were isolated from the femurs and tibias of 8 male Sprague-Dawley rats (4-week-old) following an established protocol ( ).

Techniques: CCK-8 Assay, Staining

Assessment of the osteogenic differentiation - promoting ability of PRP-CMCS-TA hydrogel. (A,B) ALP staining images of BMSCs after 7 and 14 days of different interventions. (C) Alizarin Red S staining images of BMSCs after 21 days of different interventions. (D,F) Semi-quantitative analysis of ALP activity ( (D) day 7, (E) day 14) and mineralized nodule formation ( (F) day 21) shown in (A–C) . Data are presented as mean ± SD (n = 6 independent biological samples per group). Statistical analysis was performed using one-way ANOVA. ** p < 0.01, *** p < 0.001,”ns” represents no significant difference.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: PRP-loaded hydrogel for rotator cuff repair by promoting osteogenic differentiation and tendon regeneration

doi: 10.3389/fbioe.2025.1655809

Figure Lengend Snippet: Assessment of the osteogenic differentiation - promoting ability of PRP-CMCS-TA hydrogel. (A,B) ALP staining images of BMSCs after 7 and 14 days of different interventions. (C) Alizarin Red S staining images of BMSCs after 21 days of different interventions. (D,F) Semi-quantitative analysis of ALP activity ( (D) day 7, (E) day 14) and mineralized nodule formation ( (F) day 21) shown in (A–C) . Data are presented as mean ± SD (n = 6 independent biological samples per group). Statistical analysis was performed using one-way ANOVA. ** p < 0.01, *** p < 0.001,”ns” represents no significant difference.

Article Snippet: Rat bone marrow mesenchymal stem cells (BMSCs) were isolated from the femurs and tibias of 8 male Sprague-Dawley rats (4-week-old) following an established protocol ( ).

Techniques: Staining, Activity Assay

LA@BC promoted BMSCs Osteogenic differentiation in vitro . (A) Live (green)/dead (red) staining of BMSCs after 24 h. (B) Cell proliferation of BMSCs cultured with BC, LA@BC for 24, 48 and 72 h (C) ALP staining of BMSCs after 7 days. (D) Alizarin Red S staining of BMSCs after 21 days. (E, F) Quantitative analysis of ALP staining, and Alizarin Red S staining. (G, H) Relative mRNA expression of Wnt, and β-catenin of BMSCs on day 7. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Frontiers in Pharmacology

Article Title: Probiotic biofilm modified bioceramics for bone defect healing via osteogenesis, angiogenesis, and immune modulation

doi: 10.3389/fphar.2025.1588023

Figure Lengend Snippet: LA@BC promoted BMSCs Osteogenic differentiation in vitro . (A) Live (green)/dead (red) staining of BMSCs after 24 h. (B) Cell proliferation of BMSCs cultured with BC, LA@BC for 24, 48 and 72 h (C) ALP staining of BMSCs after 7 days. (D) Alizarin Red S staining of BMSCs after 21 days. (E, F) Quantitative analysis of ALP staining, and Alizarin Red S staining. (G, H) Relative mRNA expression of Wnt, and β-catenin of BMSCs on day 7. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: The rat bone marrow mesenchymal stem cells (BMSCs) were extracted from the bone marrow cavity of 4-week-old Sprague Dawley (SD) rats and co-cultured with α-MEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution.

Techniques: In Vitro, Staining, Cell Culture, Expressing